On August 23, 2020, the US-FDA issued an Emergency Use Authorization (“EUA”) allowing the off-label use of convalescent plasma to treat COVID-19, having concluded that the totality of evidence supported this use. An EUA allows for use of an unapproved therapeutic product by clinicians when needed during public health emergencies. The FDA granted the EUA based […]
About CHHS Research Assistants & Externs
This author has yet to write their bio.
Meanwhile lets just say that we are proud CHHS Research Assistants & Externs contributed a whooping 22 entries.
Scientists began to investigate Tocilizumab in clinical trials as a possible therapy for COVID-19 because of the drug’s potent anti-inflammatory properties. Tocilizumab, a monoclonal antibody drug manufactured by Hoffman-La Roche, is marketed in the US as Actrema® and is approved for treating arthritis. Tocilizumab effectively treats arthritis by reducing the progression of inflammation in the […]
Vaccination against COVID-19 aims to produce an initial immune response to enable the body to quickly respond to attack and destroy SARS-CoV-2 whenever the vaccinated individual is later infected with the virus. All vaccines aim to expose the body to an agent, called an antigen, to provoke an initial immune response. In the initial immune […]
By CHHS Extern Arsanious Hanna Over the course of the last decade, the United States has been embroiled in a transnational cybersecurity warfare. Washington’s concerns with America’s cybersecurity infrastructure and integrity is in response to years of intelligence agency whistleblowers and cyber hacks. Whistleblowers such as former Army Intelligence Analyst Chelsea Manning, and former NSA […]
CORTICOSTEROID HORMONES AND COVID-19 Introduction. The corticosteroid hormone drugs Dexamethasone and Methylprednisolone have both been successfully used to treat COVID-19 patients. Dexamethasone, approved by the FDA in 1958, is marketed for treating severe or incapacitating allergic conditions. Methylprednisolone, approved by the FDA in 1959, is marketed for treating severe allergic conditions and some types of […]
By CHHS Extern Carly Yost Public health jargon, previously only known by professionals in the field, is now a part of most people’s everyday vernacular. Due to the global pandemic caused by the emergence of COVID-19, contact tracing is among those previously unknown terms that are now a part of everyone’s daily lives. Several large […]
By CHHS Extern Arsanious Hana As the COIVD-19 pandemic continues, many Americans are asking if state government regulations mandating the use of masks in public areas are constitutional. To address the constitutionality of state regulations regarding masks, it is crucial to turn to case law precedent set by the United States Supreme Court in the […]
By CHHS Extern Cheryl Gordon Twitter, Facebook, Google. These social media sites have become ubiquitous in American culture. While some use them more than others, we all use these social media sites for various purposes. We keep in touch with friends and colleagues. We meet new friends and network. We suggest new activities and provide […]
By CHHS Extern Nicky Arenberg Nissin With billions of people around the globe staying home due to the Covid-19 pandemic, an increasing amount of social and business meetings have moved to the different video conferencing platforms available today. Among this wide software offer, Zoom has become one of the most popular options: as the go-to […]
By CHHS Extern Sharon Sidhu President Trump declared a national emergency over the coronavirus COVID-19 pandemic on Friday afternoon, “unleash[ing] the full power of the federal government.” This action, under the authority of the Stafford Act, opened up access to up to $50 billion for states, territories, and localities, to use towards the shared fight […]
The University of Maryland Center for Health and Homeland Security (CHHS) is a non-profit consulting group and academic center committed to maximizing organizational resilience before, during and after an emergency event.
500 W. Baltimore St
Baltimore, MD 21201
(410) 706-2726 (Fax)